Jumbo (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa it stimulates alpha‑1 and alpha‑2 receptors, causing vasoconstriction of the nasal blood vessels. This reduces mucosal edema and opens the airway.

The appropriate dose of Jumbo is determined by the prescribing healthcare professional based on the patient’s age, condition, and response. Patients should follow the prescriber’s instructions and the product label for the number of sprays per dose and frequency of use.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Jumbo.

To order Jumbo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Jumbo’s active ingredient, Xylometazoline Hydrochloride, belongs to the imidazoline class, which typically provides rapid onset of action and a duration of 6‑8 hours. Compared with phenylephrine‑based sprays, it may offer longer relief with a lower incidence of systemic side effects, though individual response can vary.

Store Jumbo at ambient temperature, below 25 °C. Keep the bottle in its original packaging, protect it from moisture and direct heat, and ensure the cap is tightly closed to maintain product stability.

Jumbo is administered as a nasal spray. The user tilts the head slightly forward, inserts the nozzle into one nostril, and sprays the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed by the prescriber.

Serious risks, though rare, include severe hypertension, cardiac arrhythmias, nasal ulceration or perforation, and anaphylaxis. Prolonged use beyond the recommended duration can lead to rebound congestion (rhinitis medicamentosa). Patients should seek medical attention if they experience any of these symptoms.

Jumbo should not be used by children under six years of age, individuals with known hypersensitivity to Xylometazoline Hydrochloride or any excipients, and patients with severe hypertension or certain cardiovascular conditions unless advised by a physician.